Submit Manuscript now
Impact Factor 4.452

admin

Rs1310191201(C>T) Polymorphism in 3‘UTR of BIRC5promote Carcinogenesis of Human Gastric Cancer by De-Regulation by Mir-330-5p in Chinese Population

Leave a Comment / Issue 9 Articles, Volume 4 / By

1. Abstract Previous reports have revealed that down-regulation of miR-330-5p expression can promote os- teosarcoma growth and invasion by targeting oncogene Baculoviral IAP repeat-containing pro- tein 5 (BIRC5). However, the function of the single nucleotide polymorphism (SNP) located in the 3’UTR of BIRC5 regulated by miR-330-5p has not been investigated in human Gastric Can- cer …

Rs1310191201(C>T) Polymorphism in 3‘UTR of BIRC5promote Carcinogenesis of Human Gastric Cancer by De-Regulation by Mir-330-5p in Chinese Population Read More »

Rapid SARS-Cov-2 Infection Spreading within a Family Cluster: The Importance of Gastro-Intestinal Symptoms

Leave a Comment / Issue 9 Articles, Volume 4 / By

1. Abstract 1.1. Background: In Phase-2 COVID-19 pandemic, timely control of new outbreaks is pivotal to avoid an epidemic rebound. A better knowledge of clinical disease profiles and the development of sensitive diagnostic flow charts will help to take more effectiveactions. 1.2. Patients and Methods: We studied an outbreak occurred in 3 families during a …

Rapid SARS-Cov-2 Infection Spreading within a Family Cluster: The Importance of Gastro-Intestinal Symptoms Read More »

Bcl-2 and SIRT3 Affect Tumor Cell Viability by Integrating Metabolism and Apoptosis

Leave a Comment / Issue 9 Articles, Volume 4 / By

While apoptotic tolerance caused by B cell lymphoma 2 (Bcl-2) over expression is one of the important underlying mechanisms of the decreased apoptotic sensitivity of tumor cells, only tar- geting Bcl-2 as an anticancer therapy has shown limited clinical benefit, which may be related to the non-apoptotic protective effects of Bcl-2, such as its roles …

Bcl-2 and SIRT3 Affect Tumor Cell Viability by Integrating Metabolism and Apoptosis Read More »

Undertreatment of Hepatitis C Virus Infection in Elective Total Hip Arthroplasty

Leave a Comment / Volume 4 / By

Total Hip Arthroplasty (THA) in patients with hepatitis C virus (HCV) are known for poor outcomes increased risk of iatrogenic infection. New Direct Antiviral Agents (DAA) can now cure HCV infection. However, undertreatment is still common in patients undergoing THA. Our aim was to assess the prevalence of HCV infection and treatment rates inpatients with …

Undertreatment of Hepatitis C Virus Infection in Elective Total Hip Arthroplasty Read More »

Perspectives on Minimally Invasive Approach to Resection of Colorectal Liver Metastases

Leave a Comment / Issue 8 Articles, Volume 4 / By

Surgical resection is the most effective treatment approach in colorectal liver metastases. The im-proved survival in stage IV colorectal cancer is associated with a better diagnosis and evaluation, proper decision making, improved chemotherapy, and the adoption of parenchymal-sparing he-patic resections. Liver surgery was one of the last frontiers reached by minimally invasive surgery. Surgical techniques …

Perspectives on Minimally Invasive Approach to Resection of Colorectal Liver Metastases Read More »

An Uncommon Presentation of a Common Rectal Condition

Leave a Comment / Issue 7 Articles, Volume 4 / By

We report a case of Solitary Rectal Ulcer Syndrome (SRUS) whose colonoscopy showed a rectal mass whose large pale appearance was uncommon and should be remembered as a presentation of SRUS. SRUS is a chronic, benign disorder commonly caused by consti-pation – clinical features can comprise of rectal bleeding, passage of mucous, rectal pain, tenesmus, …

An Uncommon Presentation of a Common Rectal Condition Read More »

What Our Author Say's

I am glad that I found this platform. It was easy to get my research published and I was guided at every step. I highly recommend them.
Shuang-Qin Yi
am grateful to the Japanese Journal of Gastroenterology and Hepatology for helping me with my research and publishing it. Looking forward to more work with them.
Makki Fayadh
It has been a pleasure working with the Japanese Journal of Gastroenterology and Hepatology. They have been amazing in helping me with my manuscript
Han Min
I am glad that I submitted my manuscript here. They helped me make necessary edits and published the best version of it. I highly recommend them.
Sadaf Saleem

FAQ's About Jajgastrohepto

The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.

For Detailed quotations reach out submission@jajogh.jp

It depends on the length of the manuscript and the reviews and edits needed.

We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.

A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.

Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.

*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.

Copyright 2018-2024 All Rights Reserved.